Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Deneau

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Journal of Pediatric Gastroenterology and Nutrition|December 17, 2016
Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology CommitteesLawrence J Saubermann, Mark Deneau, Richard A Falcone, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 20, 2024
Determining the time to cholangiocarcinoma in pediatric-onset PSC-IBDBatul Kaj-Carbaidwala, Johan Fevery, Douglas G Adler, et al.
Pediatrics|October 21, 2015
Incidence and Characteristics of Autoimmune HepatitisCarolina Jiménez-Rivera, Simon C Ling, Najma Ahmed, et al.
The Journal of Pediatrics|March 18, 2019
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical CourseMark Deneau, Emily Perito, Amanda Ricciuto, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 27, 2022
Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North AmericaBasavaraj Kerur, Karoline Fiedler, Marisa Stahl, et al.
Inflammatory Bowel Diseases|May 10, 2020
Natural History of  Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort StudyBasavaraj Kerur, Eric I Benchimol, Karoline Fiedler, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2026
Longitudinal GGT Trajectories Identify Prognostic Phenotypes in Paediatric Primary Sclerosing CholangitisDaniela Denier, Yiming Emmett Peng, Mansi Amin, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC ConsortiumAmanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Journal of Hepatology|February 10, 2022
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantationAldo J Montano-Loza, Vincenzo Ronca, Maryam Ebadi, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survivalVincenzo Ronca, Alessandro Parente, Ellina Lytvyak, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Journal of Pediatric Gastroenterology and Nutrition|December 17, 2016
Hepatic Issues and Complications Associated With Inflammatory Bowel Disease: A Clinical Report From the NASPGHAN Inflammatory Bowel Disease and Hepatology CommitteesLawrence J Saubermann, Mark Deneau, Richard A Falcone, et al.
Journal of Pediatric Gastroenterology and Nutrition|December 20, 2024
Determining the time to cholangiocarcinoma in pediatric-onset PSC-IBDBatul Kaj-Carbaidwala, Johan Fevery, Douglas G Adler, et al.
Pediatrics|October 21, 2015
Incidence and Characteristics of Autoimmune HepatitisCarolina Jiménez-Rivera, Simon C Ling, Najma Ahmed, et al.
The Journal of Pediatrics|March 18, 2019
Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical CourseMark Deneau, Emily Perito, Amanda Ricciuto, et al.
Journal of Pediatric Gastroenterology and Nutrition|May 27, 2022
Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease: A Multicenter Retrospective Cohort Study From North AmericaBasavaraj Kerur, Karoline Fiedler, Marisa Stahl, et al.
Inflammatory Bowel Diseases|May 10, 2020
Natural History of  Very Early Onset Inflammatory Bowel Disease in North America: A Retrospective Cohort StudyBasavaraj Kerur, Eric I Benchimol, Karoline Fiedler, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2026
Longitudinal GGT Trajectories Identify Prognostic Phenotypes in Paediatric Primary Sclerosing CholangitisDaniela Denier, Yiming Emmett Peng, Mansi Amin, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC ConsortiumAmanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Journal of Hepatology|February 10, 2022
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantationAldo J Montano-Loza, Vincenzo Ronca, Maryam Ebadi, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survivalVincenzo Ronca, Alessandro Parente, Ellina Lytvyak, et al.
Pageof 3